Bundang Seoul National University Hospital Signs MOU to Establish 'International PSP Treatment Center'
Dec 08, 2024
Bundang Seoul National University Hospital announced on the 6th that it signed a trilateral memorandum of understanding (MOU) with CurePSP and Gembax & KL to establish an 'international PSP treatment center".
The signing ceremony was held in the conference room of Seoul National University Bundang Hospital, attended by major officials, including Song Jeong-han, director of Bundang Seoul National University Hospital, Jeon Sang-hoon, professor of cardiovascular and thoracic surgery, Dr. Christoph Diaz, chief executive officer of CurePSP, and CEO of Gembax & Kael Lee Seok-jun.
Progressive Supranucial Palsy (PSP) is a neurodegenerative disease that occurs when certain parts of the brain are gradually damaged and is a rare incurable disease that currently has no fundamental treatment. The International PSP Treatment Center plans to serve as an international hub for the treatment of neurodegenerative diseases and also treat and manage addiction-related diseases such as drugs.
Through this agreement, the three organizations decided to cooperate in overall treatment, education, research, and new drug development and commercialization using each institution's expertise and resources to overcome neurodegenerative diseases.
Bundang Seoul National University Hospital will support the stable operation of the center and contribute to the advancement of treatment, education, and research. The U.S. non-profit charity CurePSP will support the overall operation, including the establishment of international infrastructure, while GemVax & Kael will support the funding and overall operation of the center and lead the research and development and commercialization of PSP therapeutic drugs.
Director Song Jeong-han of Seoul National University Bundang Hospital said "We expect the establishment of an international PSP treatment center to be an important turning point in providing practical help to patients with rare and intractable diseases.""Based on cooperation with CurePSP and GemVax & KL, Bundang Seoul National University Hospital will actively support them to play a leading role in research and treatment development for overcoming neurodegenerative diseases." he said.
Professor Sang-Hoon Jeon of Seoul National University Bundang Hospital said, `We hope that the international PSP treatment center will contribute to overcoming rare and intractable diseases such as PSP and develop into a global center for fostering excellent professionals and improving research capabilities.'
The signing ceremony was held in the conference room of Seoul National University Bundang Hospital, attended by major officials, including Song Jeong-han, director of Bundang Seoul National University Hospital, Jeon Sang-hoon, professor of cardiovascular and thoracic surgery, Dr. Christoph Diaz, chief executive officer of CurePSP, and CEO of Gembax & Kael Lee Seok-jun.
Progressive Supranucial Palsy (PSP) is a neurodegenerative disease that occurs when certain parts of the brain are gradually damaged and is a rare incurable disease that currently has no fundamental treatment. The International PSP Treatment Center plans to serve as an international hub for the treatment of neurodegenerative diseases and also treat and manage addiction-related diseases such as drugs.
Through this agreement, the three organizations decided to cooperate in overall treatment, education, research, and new drug development and commercialization using each institution's expertise and resources to overcome neurodegenerative diseases.
Bundang Seoul National University Hospital will support the stable operation of the center and contribute to the advancement of treatment, education, and research. The U.S. non-profit charity CurePSP will support the overall operation, including the establishment of international infrastructure, while GemVax & Kael will support the funding and overall operation of the center and lead the research and development and commercialization of PSP therapeutic drugs.
Director Song Jeong-han of Seoul National University Bundang Hospital said "We expect the establishment of an international PSP treatment center to be an important turning point in providing practical help to patients with rare and intractable diseases.""Based on cooperation with CurePSP and GemVax & KL, Bundang Seoul National University Hospital will actively support them to play a leading role in research and treatment development for overcoming neurodegenerative diseases." he said.
Professor Sang-Hoon Jeon of Seoul National University Bundang Hospital said, `We hope that the international PSP treatment center will contribute to overcoming rare and intractable diseases such as PSP and develop into a global center for fostering excellent professionals and improving research capabilities.'
|
This article was translated by Naver AI translator.
